INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$0

$0

Total Sells (Filtered)

$15.7M

$15,705,142

View Raw Line-Items

Live Feed: 2026-03-11

Timeline

Side

Size

All $1M+ $5M+ $10M+

Role

Ticker Search

Clear Clear Filters

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
IONS S IONIS PHARMACEUTICALS INC Jenne Kyle • Officer • EVP, Chf GL Pdt Str Ofcr 10b5-1 SellΔOwn -43.2% 2026-03-10 $2,827,325Largex2 View Form 4 →
IONS	IONIS PHARMACEUTICALS INC	Jenne Kyle Officer • EVP, Chf GL Pdt Str Ofcr 10b5-1 SellΔOwn -43.2%	2026-03-10	$2,827,325Largex2	S	Form 4
IONS S IONIS PHARMACEUTICALS INC Monia Brett P • CEO 10b5-1 Sell 2026-03-10 $2,589,144Largex2 View Form 4 →
IONS	IONIS PHARMACEUTICALS INC	Monia Brett P CEO 10b5-1 Sell	2026-03-10	$2,589,144Largex2	S	Form 4
IONS S IONIS PHARMACEUTICALS INC Monia Brett P • CEO 10b5-1 Sell 2026-03-09 $9,525,011Whalex3 View Form 4 →
IONS	IONIS PHARMACEUTICALS INC	Monia Brett P CEO 10b5-1 Sell	2026-03-09	$9,525,011Whalex3	S	Form 4
IONS S IONIS PHARMACEUTICALS INC O'NEIL PATRICK R. • Officer • EVP CLO & General Counsel 10b5-1 SellΔOwn -14.0% 2026-03-09 $763,662 View Form 4 →
IONS	IONIS PHARMACEUTICALS INC	O'NEIL PATRICK R. Officer • EVP CLO & General Counsel 10b5-1 SellΔOwn -14.0%	2026-03-09	$763,662	S	Form 4